Century Therapeutics, Inc. (IPSC) Net income 2020–2025
Century Therapeutics, Inc. (IPSC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$9.6MFY2025 · since FY2020: -$53.6M → -$9.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.6M | +92.4% |
| FY2024 | -$126.6M | +7.4% |
| FY2023 | -$136.7M | -4.4% |
| FY2022 | -$130.9M | -36.6% |
| FY2021 | -$95.8M | -78.9% |
| FY2020 | -$53.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IPSC financial trends
IPSC RevenueIPSC Net marginIPSC Gross profitIPSC Gross marginIPSC Operating incomeIPSC Operating marginIPSC Operating cash flowIPSC Free cash flowIPSC Capital expendituresIPSC Return on equityIPSC Stock buybacksIPSC Dividends paidIPSC Total assetsIPSC Total liabilitiesIPSC Shareholders’ equityIPSC overview →